Sandra G. Stoneman - 31 Jan 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMNM	Stock option (right to buy)	Award	$0	+200,000		$0.000000	200,000	31 Jan 2024	Common Stock	200,000	$16.57	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.